Hemoximer pyridoxalated hemoglobin polyoxyethylene: Interim Phase III data

Curacyte terminated the European Phase III PHOENIX trial after an interim analysis by an independent DMB showed a higher number of deaths in the PHP arm compared to the placebo arm. The DMB concluded ...